Affitech A/S
Due date extended for short term loan provided by Trans Nova
Affitech A/S 12.10.2012 16:06 Dissemination of a Adhoc News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. --------------------------------------------------------------------------- Release no. 29/2012 Copenhagen and Oslo, 12th October 2012, 2012-10-12 16:06 CEST (GLOBE NEWSWIRE) -- Affitech A/S, (NASDAQ OMX: AFFI), the antibody medicines company, announced today that Trans Nova Investments Limited, the largest shareholder in Affitech A/S with 76,78% ownership has agreed to extend the due date for the Euro 1.5 million short term loan provided in July 2012 and paid to Affitech in three tranches in July, August and September 2012 . The due date has been extended from 16th October, 2012 until 16th January, 2013. The other conditions for the loan remain unchanged. About Affitech Affitech A/S is a publicly traded (NASDAQ OMX Copenhagen) biotech company headquartered in Copenhagen, Denmark with R&D facilities in Oslo, Norway. The company utilizes a range of proprietary antibody technologies for the discovery of fully human antibodies for application in oncology, inflammation and other disease areas. Affitech A/S antibody drugs targeting molecules on the cell surface are developed through the Company's proprietary CBAS(TM) (Cell Based Antibody Selection). Affitech develops its two leading antibody drug candidates AT001/r84 and AT008/CCR4 in collaboration with its Russian partner IBC Generium. Further information is available at www.affitech.com. Contact: Stig Jarle Pettersen, CFO Tel +47 9096 0336 Randi Krogsgaard, Director IR & Communications Tel # +45 2320 1001, e-mail: ir@affitech.com News Source: NASDAQ OMX 12.10.2012 DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Affitech A/S Denmark Phone: Fax: E-mail: Internet: ISIN: DK0015966592 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Aktuelle News
Aktuelle Berichte
Keine Berichte gefunden
Anstehende Events
Keine Events gefunden
Webcasts
Keine Webcasts gefunden